INSIST! Metastatic Breast Cancer
December 2025
Insist! on Better Care
Biomarker testing in Metastatic Breast Cancer is essential to ensure patients are receiving the best, most personalized care available. The goal of INSIST! Metastatic Breast Cancer is to educate and empower patients and care partners to speak up and insist on better care.
Program topics include:
Personalize Your Experience!
Create an account to save items and receive information curated just for you.
Understanding Testing in Metastatic Breast Cancer

Self-Advocacy | Why In-Depth Cancer Testing Is Essential
December 5, 2025

Molecular Testing and Hereditary Testing: What’s the Difference?
December 5, 2025

When Should Someone With Cancer Undergo Molecular Testing?
November 6, 2025

What Is Molecular Testing and Why Is It Necessary in Cancer Care?
November 6, 2025

What Is a Breast Cancer Genetic Mutation?
April 14, 2023


What Is Breast Cancer Genomic Testing?
April 14, 2023


Genetic Testing VS Biomarker Testing: What’s the Difference?
March 30, 2023




Managing Metastatic Breast Cancer Symptoms
September 3, 2021

What is Metastatic Breast Cancer and How Is It Diagnosed?
September 3, 2021

Is the COVID-19 Vaccine Safe and Effective for Breast Cancer Patients?
September 3, 2021
Metastatic Breast Cancer Treatment Decisions

What Does Breast Cancer Hormone Receptor Status Mean?
April 14, 2023




An Expert Review of Emerging Metastatic Breast Cancer Research
September 22, 2021

How Do Genetic Mutations Impact Breast Cancer Risk, Prognosis and Treatment?
September 22, 2021

Is Your Metastatic Breast Cancer Treatment Effective?
September 3, 2021

Why Should Metastatic Breast Cancer Patients Consider a Clinical Trial?
September 3, 2021



An Overview of Metastatic Breast Cancer Treatment Options
September 3, 2021
INSIST! Metastatic Breast Cancer Resources

INSIST! Breast Cancer Resource Guide
April 18, 2023

Which Metastatic Breast Cancer Treatment Is Right for You? Guide
August 25, 2021

Understanding Metastatic Breast Cancer Resource Guide
September 28, 2020
This program is supported by Daiichi-Sankyo, Exact Sciences, Foundation Medicine, Novartis, and Pfizer, and through generous donations from people like you.